
CMV (Cytomegalovirus) Avidity









The CMV (Cytomegalovirus) Avidity test is a blood test that evaluates the binding strength (avidity) of IgG antibodies against CMV. It helps differentiate between a recent (primary) CMV infection and a past infection or immunity, which is especially important during pregnancy.













Understanding CMV (Cytomegalovirus) Avidity
Cytomegalovirus (CMV) is a widespread virus that generally causes mild or no symptoms in healthy individuals. When present, CMV may lead to nonspecific complaints such as fever, sore throat, swollen lymph nodes, body aches, or prolonged fatigue. Since many people remain asymptomatic, they may be unaware of ever having been infected.
While CMV infections are typically harmless in healthy individuals, they can cause significant health concerns in certain groups. Pregnant women face risks, as a recent infection may be transmitted to the fetus, potentially leading to congenital CMV, which can cause hearing loss, vision problems, or developmental delays. Similarly, individuals with weakened immune systems, such as transplant recipients or those with HIV, may experience severe complications due to CMV reactivation.
The CMV (Cytomegalovirus) Avidity test helps clarify whether a CMV infection is recent or occurred in the past. After the body encounters CMV, IgG antibodies are produced. Initially, these antibodies have low avidity (weak binding strength). Over time, the immune system matures these antibodies, resulting in high avidity (strong binding strength). By assessing this binding strength, the test distinguishes between a primary infection (recent) and a past or reactivated infection.
Usually, no special preparation is needed for this test. Eat and drink as per the daily routine. However, it is preferred to provide the doctor with the clinical history before giving the sample.
Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results.
Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.
What does CMV (Cytomegalovirus) Avidity measure?
The CMV (Cytomegalovirus) Avidity test measures the binding strength (avidity) of CMV-specific IgG antibodies in the blood. When a person is newly infected with CMV, the IgG antibodies produced are of low avidity, meaning they bind weakly to the virus. This low avidity usually indicates a recent primary infection within the last 3–4 months. Over time, as the immune response matures, the IgG antibodies gain high avidity, binding more strongly to the virus, which reflects a past infection or established immunity due to earlier exposure or vaccination. By distinguishing between recent and past infections, this test provides crucial insights for clinical decision-making. It is especially useful in high-risk groups such as pregnant women, where a recent infection may affect the fetus. It is also important for individuals with weakened immune systems, where CMV reactivation can lead to serious complications.





FAQs related to CMV (Cytomegalovirus) Avidity
- About Cytomegalovirus (CMV) [Internet]. CDC; 17 Jan. 2025 [Accessed 11 Sep. 2025]. Available from:
- Cytomegalovirus (Blood) [Internet]. Rochester, NY: University of Rochester Medical Center; [Accessed 11 Sep. 2025]. Available from:
- Nguyen AD, Shorman M. Cytomegalovirus Infections. [Updated 2025 Dec 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:
- Prince HE, Lapé-Nixon M. Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy. Clin Vaccine Immunol. 2014 Oct;21(10):1377-84. [Accessed 11 Sep. 2025]. Available from:
- Abdullahi Nasir I, Babayo A, Shehu MS. Clinical Significance of IgG Avidity Testing and Other Considerations in the Diagnosis of Congenital Cytomegalovirus Infection: A Review Update. Med Sci (Basel). 2016 Mar 8;4(1):5. [Accessed 11 Sep. 2025]. Available from:
- Ziebold C, Pillarisetty LS. Congenital Cytomegalovirus Infection. [Updated 2025 Aug 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:
Other tests
- PT INR (Prothrombin Time with INR)
- HIV 1 and 2 Antibody, Rapid Screening Test
- Viral Marker Screening (HIV, HBsAg, Anti-HCV)
- Total IgE
- Rheumatoid Factor - Quantitative
- STD Panel (Sexually Transmitted Diseases Panel)
- HIV Combo (Antigen And Antibody) Test
- Anti-CCP Antibody
- Lipid Profile, Non Fasting
- Influvac Tetra 2025/2026 Vaccine (Vaccination at Home)
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)
























